• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术后心脏。心脏移植病理学。

The postsurgical heart. The pathology of cardiac transplantation.

作者信息

Billingham M E

机构信息

Department of Pathology, Stanford University Medical School, California 94305.

出版信息

Am J Cardiovasc Pathol. 1988;1(3):319-34.

PMID:3061403
Abstract

Cardiac transplantation offers an excellent chance of long-term survival and functional rehabilitation for the carefully selected patient with end-stage heart disease. The role played by the pathologist in the management of cardiac transplant recipients is a very important one. Although much work is being carried out currently on noninvasive procedures to predict acute rejection, at this time the morphological index of rejection by endomyocardial biopsy is still the only reliable one. Noninvasive techniques are more sensitive because the whole heart can be studied; however, they are still much less specific and cannot distinguish infection from rejection or ischemia. The current management and survival of cardiac allografts depends as much on the pathologist as on his clinical colleagues.

摘要

心脏移植为精心挑选的终末期心脏病患者提供了长期存活和功能康复的绝佳机会。病理学家在心脏移植受者的管理中所起的作用非常重要。尽管目前正在开展许多关于预测急性排斥反应的非侵入性检查,但此时,心内膜活检的排斥反应形态学指标仍是唯一可靠的指标。非侵入性技术更为敏感,因为可以对整个心脏进行研究;然而,它们的特异性仍然低得多,无法区分感染、排斥反应或缺血。目前心脏异体移植的管理和存活率同样取决于病理学家及其临床同事。

相似文献

1
The postsurgical heart. The pathology of cardiac transplantation.术后心脏。心脏移植病理学。
Am J Cardiovasc Pathol. 1988;1(3):319-34.
2
The pathology of transplanted hearts.移植心脏的病理学
Semin Thorac Cardiovasc Surg. 1990 Jul;2(3):233-40.
3
The pathology of heart allograft rejection.
Arch Pathol Lab Med. 1991 Mar;115(3):266-72.
4
Cardiac transplantation.心脏移植
Cardiovasc Clin. 1988;18(2):185-99.
5
Acute rejection and endomyocardial biopsy after heart transplantation.
Cor Vasa. 1990;32(5):395-400.
6
Heart transplantation in Norway. Morphological monitoring of cardiac allograft rejection. A 3-year follow-up.挪威的心脏移植。心脏同种异体移植排斥反应的形态学监测。一项为期3年的随访研究。
APMIS. 1988 Jan;96(1):14-24.
7
Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.小儿心脏移植受者心内膜心肌活检样本中活化淋巴细胞体外增殖的临床相关性
Pediatr Transplant. 1998 Aug;2(3):200-5.
8
Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.通过心内膜心肌活检评估不同免疫抑制方案下的心脏同种异体移植排斥反应。
J Heart Transplant. 1986 Jul-Aug;5(4):279-85.
9
Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.心脏移植术后一年以上,常规监测性心肌活检并无必要。
J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 1):1052-6.
10
Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.利用聚合酶链反应对小儿心脏移植受者的病毒感染进行诊断、监测和流行病学评估。
J Heart Lung Transplant. 1996 Feb;15(2):111-23.

引用本文的文献

1
Comparison of Gal and non-Gal-mediated cardiac xenograft rejection.Gal 与非 Gal 介导的心脏异种移植排斥反应的比较。
Transplantation. 2011 May 15;91(9):968-75. doi: 10.1097/TP.0b013e318212c7fe.
2
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.慢性排斥反应。组织病理学和病理生理学概述,重点关注肝、心脏和肠道同种异体移植。
Ann Transplant. 1997;2(2):27-44.
3
Enhanced lymphocyte longevity and absence of proliferation and lymphocyte apoptosis in Quilty effects of human heart allografts.
人心脏同种异体移植的奎尔蒂效应中淋巴细胞寿命延长、无增殖及淋巴细胞凋亡。
Am J Pathol. 1997 Jul;151(1):121-30.
4
Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption.慢性排斥反应与闭塞性动脉病分析。供体抗原呈递细胞和淋巴系统破坏的可能作用。
Am J Pathol. 1997 Feb;150(2):563-78.
5
Therapeutic approaches to the control of fibrocellular intimal hyperplasia after angioplasty.血管成形术后控制纤维细胞内膜增生的治疗方法。
Br Heart J. 1993 Jul;70(1):1-3. doi: 10.1136/hrt.70.1.1.
6
Graft vascular disease in heart transplant patients.心脏移植患者的移植物血管疾病
Br Heart J. 1992 Sep;68(3):253-4. doi: 10.1136/hrt.68.9.253.